The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Adenosine Cobalamin Market Research Report 2025
Synopsis
Adenosylcobalamin is the analog of cyanocobalt type vitamin B12, i.e., its CN group is replaced by adenosine to become 5'-deoxyadenosylcobalamin, which is one of the two active coenzymes of vitamin B12 in the body and is essential for cell growth and reproduction and for maintaining the integrity of the myelin sheath of the nervous system. It is rapidly and completely absorbed after intramuscular injection, with peak plasma concentration after 1 hour, stored in the liver, and excreted mainly from the kidney, mostly in the first 8 hours.
The global Adenosine Cobalamin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Adenosine Cobalamin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adenosine Cobalamin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Adenosine Cobalamin include BL Bio Lab, Zhitong Biopharma, Fujian Gutian Pharmaceutical Co.,Ltd., Shanghai Shyndec Pharmaceutical Co.,Ltd, Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co., North China Pharmaceutical Co., Harbin Medisan Pharmaceutical Co., Ltd. and Hainan Star Pharmaceutical Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adenosine Cobalamin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adenosine Cobalamin.
Report Scope
The Adenosine Cobalamin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adenosine Cobalamin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adenosine Cobalamin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BL Bio Lab
Zhitong Biopharma
Fujian Gutian Pharmaceutical Co.,Ltd.
Shanghai Shyndec Pharmaceutical Co.,Ltd
Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co.
North China Pharmaceutical Co.
Harbin Medisan Pharmaceutical Co., Ltd.
Hainan Star Pharmaceutical Co.
Segment by Type
Tablets
Liquid
Segment by Application
Kids
Adults
Seniors
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adenosine Cobalamin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adenosine Cobalamin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Adenosylcobalamin is the analog of cyanocobalt type vitamin B12, i.e., its CN group is replaced by adenosine to become 5'-deoxyadenosylcobalamin, which is one of the two active coenzymes of vitamin B12 in the body and is essential for cell growth and reproduction and for maintaining the integrity of the myelin sheath of the nervous system. It is rapidly and completely absorbed after intramuscular injection, with peak plasma concentration after 1 hour, stored in the liver, and excreted mainly from the kidney, mostly in the first 8 hours.
The global Adenosine Cobalamin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Adenosine Cobalamin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adenosine Cobalamin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Adenosine Cobalamin include BL Bio Lab, Zhitong Biopharma, Fujian Gutian Pharmaceutical Co.,Ltd., Shanghai Shyndec Pharmaceutical Co.,Ltd, Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co., North China Pharmaceutical Co., Harbin Medisan Pharmaceutical Co., Ltd. and Hainan Star Pharmaceutical Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adenosine Cobalamin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adenosine Cobalamin.
Report Scope
The Adenosine Cobalamin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adenosine Cobalamin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adenosine Cobalamin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BL Bio Lab
Zhitong Biopharma
Fujian Gutian Pharmaceutical Co.,Ltd.
Shanghai Shyndec Pharmaceutical Co.,Ltd
Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co.
North China Pharmaceutical Co.
Harbin Medisan Pharmaceutical Co., Ltd.
Hainan Star Pharmaceutical Co.
Segment by Type
Tablets
Liquid
Segment by Application
Kids
Adults
Seniors
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adenosine Cobalamin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adenosine Cobalamin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Adenosine Cobalamin Market Overview
1.1 Product Overview and Scope of Adenosine Cobalamin
1.2 Adenosine Cobalamin Segment by Type
1.2.1 Global Adenosine Cobalamin Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Liquid
1.3 Adenosine Cobalamin Segment by Application
1.3.1 Global Adenosine Cobalamin Market Value by Application: (2024-2030)
1.3.2 Kids
1.3.3 Adults
1.3.4 Seniors
1.4 Global Adenosine Cobalamin Market Size Estimates and Forecasts
1.4.1 Global Adenosine Cobalamin Revenue 2019-2030
1.4.2 Global Adenosine Cobalamin Sales 2019-2030
1.4.3 Global Adenosine Cobalamin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Adenosine Cobalamin Market Competition by Manufacturers
2.1 Global Adenosine Cobalamin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Adenosine Cobalamin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Adenosine Cobalamin Average Price by Manufacturers (2019-2024)
2.4 Global Adenosine Cobalamin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Adenosine Cobalamin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adenosine Cobalamin, Product Type & Application
2.7 Adenosine Cobalamin Market Competitive Situation and Trends
2.7.1 Adenosine Cobalamin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Adenosine Cobalamin Players Market Share by Revenue
2.7.3 Global Adenosine Cobalamin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Adenosine Cobalamin Retrospective Market Scenario by Region
3.1 Global Adenosine Cobalamin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Adenosine Cobalamin Global Adenosine Cobalamin Sales by Region: 2019-2030
3.2.1 Global Adenosine Cobalamin Sales by Region: 2019-2024
3.2.2 Global Adenosine Cobalamin Sales by Region: 2025-2030
3.3 Global Adenosine Cobalamin Global Adenosine Cobalamin Revenue by Region: 2019-2030
3.3.1 Global Adenosine Cobalamin Revenue by Region: 2019-2024
3.3.2 Global Adenosine Cobalamin Revenue by Region: 2025-2030
3.4 North America Adenosine Cobalamin Market Facts & Figures by Country
3.4.1 North America Adenosine Cobalamin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Adenosine Cobalamin Sales by Country (2019-2030)
3.4.3 North America Adenosine Cobalamin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adenosine Cobalamin Market Facts & Figures by Country
3.5.1 Europe Adenosine Cobalamin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Adenosine Cobalamin Sales by Country (2019-2030)
3.5.3 Europe Adenosine Cobalamin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adenosine Cobalamin Market Facts & Figures by Country
3.6.1 Asia Pacific Adenosine Cobalamin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Adenosine Cobalamin Sales by Country (2019-2030)
3.6.3 Asia Pacific Adenosine Cobalamin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Adenosine Cobalamin Market Facts & Figures by Country
3.7.1 Latin America Adenosine Cobalamin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Adenosine Cobalamin Sales by Country (2019-2030)
3.7.3 Latin America Adenosine Cobalamin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Adenosine Cobalamin Market Facts & Figures by Country
3.8.1 Middle East and Africa Adenosine Cobalamin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Adenosine Cobalamin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Adenosine Cobalamin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adenosine Cobalamin Sales by Type (2019-2030)
4.1.1 Global Adenosine Cobalamin Sales by Type (2019-2024)
4.1.2 Global Adenosine Cobalamin Sales by Type (2025-2030)
4.1.3 Global Adenosine Cobalamin Sales Market Share by Type (2019-2030)
4.2 Global Adenosine Cobalamin Revenue by Type (2019-2030)
4.2.1 Global Adenosine Cobalamin Revenue by Type (2019-2024)
4.2.2 Global Adenosine Cobalamin Revenue by Type (2025-2030)
4.2.3 Global Adenosine Cobalamin Revenue Market Share by Type (2019-2030)
4.3 Global Adenosine Cobalamin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Adenosine Cobalamin Sales by Application (2019-2030)
5.1.1 Global Adenosine Cobalamin Sales by Application (2019-2024)
5.1.2 Global Adenosine Cobalamin Sales by Application (2025-2030)
5.1.3 Global Adenosine Cobalamin Sales Market Share by Application (2019-2030)
5.2 Global Adenosine Cobalamin Revenue by Application (2019-2030)
5.2.1 Global Adenosine Cobalamin Revenue by Application (2019-2024)
5.2.2 Global Adenosine Cobalamin Revenue by Application (2025-2030)
5.2.3 Global Adenosine Cobalamin Revenue Market Share by Application (2019-2030)
5.3 Global Adenosine Cobalamin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BL Bio Lab
6.1.1 BL Bio Lab Corporation Information
6.1.2 BL Bio Lab Description and Business Overview
6.1.3 BL Bio Lab Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BL Bio Lab Adenosine Cobalamin Product Portfolio
6.1.5 BL Bio Lab Recent Developments/Updates
6.2 Zhitong Biopharma
6.2.1 Zhitong Biopharma Corporation Information
6.2.2 Zhitong Biopharma Description and Business Overview
6.2.3 Zhitong Biopharma Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zhitong Biopharma Adenosine Cobalamin Product Portfolio
6.2.5 Zhitong Biopharma Recent Developments/Updates
6.3 Fujian Gutian Pharmaceutical Co.,Ltd.
6.3.1 Fujian Gutian Pharmaceutical Co.,Ltd. Corporation Information
6.3.2 Fujian Gutian Pharmaceutical Co.,Ltd. Description and Business Overview
6.3.3 Fujian Gutian Pharmaceutical Co.,Ltd. Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fujian Gutian Pharmaceutical Co.,Ltd. Adenosine Cobalamin Product Portfolio
6.3.5 Fujian Gutian Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.4 Shanghai Shyndec Pharmaceutical Co.,Ltd
6.4.1 Shanghai Shyndec Pharmaceutical Co.,Ltd Corporation Information
6.4.2 Shanghai Shyndec Pharmaceutical Co.,Ltd Description and Business Overview
6.4.3 Shanghai Shyndec Pharmaceutical Co.,Ltd Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Shyndec Pharmaceutical Co.,Ltd Adenosine Cobalamin Product Portfolio
6.4.5 Shanghai Shyndec Pharmaceutical Co.,Ltd Recent Developments/Updates
6.5 Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co.
6.5.1 Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Corporation Information
6.5.2 Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Description and Business Overview
6.5.3 Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Adenosine Cobalamin Product Portfolio
6.5.5 Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Recent Developments/Updates
6.6 North China Pharmaceutical Co.
6.6.1 North China Pharmaceutical Co. Corporation Information
6.6.2 North China Pharmaceutical Co. Description and Business Overview
6.6.3 North China Pharmaceutical Co. Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 North China Pharmaceutical Co. Adenosine Cobalamin Product Portfolio
6.6.5 North China Pharmaceutical Co. Recent Developments/Updates
6.7 Harbin Medisan Pharmaceutical Co., Ltd.
6.6.1 Harbin Medisan Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Harbin Medisan Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Harbin Medisan Pharmaceutical Co., Ltd. Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Harbin Medisan Pharmaceutical Co., Ltd. Adenosine Cobalamin Product Portfolio
6.7.5 Harbin Medisan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Hainan Star Pharmaceutical Co.
6.8.1 Hainan Star Pharmaceutical Co. Corporation Information
6.8.2 Hainan Star Pharmaceutical Co. Description and Business Overview
6.8.3 Hainan Star Pharmaceutical Co. Adenosine Cobalamin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hainan Star Pharmaceutical Co. Adenosine Cobalamin Product Portfolio
6.8.5 Hainan Star Pharmaceutical Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adenosine Cobalamin Industry Chain Analysis
7.2 Adenosine Cobalamin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adenosine Cobalamin Production Mode & Process
7.4 Adenosine Cobalamin Sales and Marketing
7.4.1 Adenosine Cobalamin Sales Channels
7.4.2 Adenosine Cobalamin Distributors
7.5 Adenosine Cobalamin Customers
8 Adenosine Cobalamin Market Dynamics
8.1 Adenosine Cobalamin Industry Trends
8.2 Adenosine Cobalamin Market Drivers
8.3 Adenosine Cobalamin Market Challenges
8.4 Adenosine Cobalamin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Adenosine Cobalamin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Adenosine Cobalamin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Adenosine Cobalamin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Adenosine Cobalamin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Adenosine Cobalamin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Adenosine Cobalamin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Adenosine Cobalamin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Adenosine Cobalamin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Adenosine Cobalamin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adenosine Cobalamin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adenosine Cobalamin, Product Type & Application
Table 12. Global Key Manufacturers of Adenosine Cobalamin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adenosine Cobalamin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Cobalamin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adenosine Cobalamin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Adenosine Cobalamin Sales by Region (2019-2024) & (K Units)
Table 18. Global Adenosine Cobalamin Sales Market Share by Region (2019-2024)
Table 19. Global Adenosine Cobalamin Sales by Region (2025-2030) & (K Units)
Table 20. Global Adenosine Cobalamin Sales Market Share by Region (2025-2030)
Table 21. Global Adenosine Cobalamin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Adenosine Cobalamin Revenue Market Share by Region (2019-2024)
Table 23. Global Adenosine Cobalamin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Adenosine Cobalamin Revenue Market Share by Region (2025-2030)
Table 25. North America Adenosine Cobalamin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Adenosine Cobalamin Sales by Country (2019-2024) & (K Units)
Table 27. North America Adenosine Cobalamin Sales by Country (2025-2030) & (K Units)
Table 28. North America Adenosine Cobalamin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Adenosine Cobalamin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Adenosine Cobalamin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Adenosine Cobalamin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Adenosine Cobalamin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Adenosine Cobalamin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Adenosine Cobalamin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Adenosine Cobalamin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Adenosine Cobalamin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Adenosine Cobalamin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Adenosine Cobalamin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Adenosine Cobalamin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Adenosine Cobalamin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Adenosine Cobalamin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Adenosine Cobalamin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Adenosine Cobalamin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Adenosine Cobalamin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Adenosine Cobalamin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Adenosine Cobalamin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Adenosine Cobalamin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Adenosine Cobalamin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Adenosine Cobalamin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Adenosine Cobalamin Sales (K Units) by Type (2019-2024)
Table 51. Global Adenosine Cobalamin Sales (K Units) by Type (2025-2030)
Table 52. Global Adenosine Cobalamin Sales Market Share by Type (2019-2024)
Table 53. Global Adenosine Cobalamin Sales Market Share by Type (2025-2030)
Table 54. Global Adenosine Cobalamin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Adenosine Cobalamin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Adenosine Cobalamin Revenue Market Share by Type (2019-2024)
Table 57. Global Adenosine Cobalamin Revenue Market Share by Type (2025-2030)
Table 58. Global Adenosine Cobalamin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Adenosine Cobalamin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Adenosine Cobalamin Sales (K Units) by Application (2019-2024)
Table 61. Global Adenosine Cobalamin Sales (K Units) by Application (2025-2030)
Table 62. Global Adenosine Cobalamin Sales Market Share by Application (2019-2024)
Table 63. Global Adenosine Cobalamin Sales Market Share by Application (2025-2030)
Table 64. Global Adenosine Cobalamin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Adenosine Cobalamin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Adenosine Cobalamin Revenue Market Share by Application (2019-2024)
Table 67. Global Adenosine Cobalamin Revenue Market Share by Application (2025-2030)
Table 68. Global Adenosine Cobalamin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Adenosine Cobalamin Price (US$/Unit) by Application (2025-2030)
Table 70. BL Bio Lab Corporation Information
Table 71. BL Bio Lab Description and Business Overview
Table 72. BL Bio Lab Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. BL Bio Lab Adenosine Cobalamin Product
Table 74. BL Bio Lab Recent Developments/Updates
Table 75. Zhitong Biopharma Corporation Information
Table 76. Zhitong Biopharma Description and Business Overview
Table 77. Zhitong Biopharma Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Zhitong Biopharma Adenosine Cobalamin Product
Table 79. Zhitong Biopharma Recent Developments/Updates
Table 80. Fujian Gutian Pharmaceutical Co.,Ltd. Corporation Information
Table 81. Fujian Gutian Pharmaceutical Co.,Ltd. Description and Business Overview
Table 82. Fujian Gutian Pharmaceutical Co.,Ltd. Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Fujian Gutian Pharmaceutical Co.,Ltd. Adenosine Cobalamin Product
Table 84. Fujian Gutian Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 85. Shanghai Shyndec Pharmaceutical Co.,Ltd Corporation Information
Table 86. Shanghai Shyndec Pharmaceutical Co.,Ltd Description and Business Overview
Table 87. Shanghai Shyndec Pharmaceutical Co.,Ltd Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Shanghai Shyndec Pharmaceutical Co.,Ltd Adenosine Cobalamin Product
Table 89. Shanghai Shyndec Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 90. Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Corporation Information
Table 91. Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Description and Business Overview
Table 92. Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Adenosine Cobalamin Product
Table 94. Hebei Hengxiang Pharmaceutical Group Bianchi Pharmaceutical Co. Recent Developments/Updates
Table 95. North China Pharmaceutical Co. Corporation Information
Table 96. North China Pharmaceutical Co. Description and Business Overview
Table 97. North China Pharmaceutical Co. Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. North China Pharmaceutical Co. Adenosine Cobalamin Product
Table 99. North China Pharmaceutical Co. Recent Developments/Updates
Table 100. Harbin Medisan Pharmaceutical Co., Ltd. Corporation Information
Table 101. Harbin Medisan Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Harbin Medisan Pharmaceutical Co., Ltd. Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Harbin Medisan Pharmaceutical Co., Ltd. Adenosine Cobalamin Product
Table 104. Harbin Medisan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Hainan Star Pharmaceutical Co. Corporation Information
Table 106. Hainan Star Pharmaceutical Co. Description and Business Overview
Table 107. Hainan Star Pharmaceutical Co. Adenosine Cobalamin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hainan Star Pharmaceutical Co. Adenosine Cobalamin Product
Table 109. Hainan Star Pharmaceutical Co. Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Adenosine Cobalamin Distributors List
Table 113. Adenosine Cobalamin Customers List
Table 114. Adenosine Cobalamin Market Trends
Table 115. Adenosine Cobalamin Market Drivers
Table 116. Adenosine Cobalamin Market Challenges
Table 117. Adenosine Cobalamin Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Adenosine Cobalamin
Figure 2. Global Adenosine Cobalamin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Adenosine Cobalamin Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Adenosine Cobalamin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Adenosine Cobalamin Market Share by Application in 2023 & 2030
Figure 8. Kids
Figure 9. Adults
Figure 10. Seniors
Figure 11. Global Adenosine Cobalamin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Adenosine Cobalamin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Adenosine Cobalamin Sales (2019-2030) & (K Units)
Figure 14. Global Adenosine Cobalamin Average Price (US$/Unit) & (2019-2030)
Figure 15. Adenosine Cobalamin Report Years Considered
Figure 16. Adenosine Cobalamin Sales Share by Manufacturers in 2023
Figure 17. Global Adenosine Cobalamin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Adenosine Cobalamin Players: Market Share by Revenue in 2023
Figure 19. Adenosine Cobalamin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Adenosine Cobalamin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Adenosine Cobalamin Sales Market Share by Country (2019-2030)
Figure 22. North America Adenosine Cobalamin Revenue Market Share by Country (2019-2030)
Figure 23. United States Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Adenosine Cobalamin Sales Market Share by Country (2019-2030)
Figure 26. Europe Adenosine Cobalamin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Adenosine Cobalamin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Adenosine Cobalamin Revenue Market Share by Region (2019-2030)
Figure 34. China Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Adenosine Cobalamin Sales Market Share by Country (2019-2030)
Figure 44. Latin America Adenosine Cobalamin Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Adenosine Cobalamin Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Adenosine Cobalamin Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Adenosine Cobalamin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Adenosine Cobalamin by Type (2019-2030)
Figure 54. Global Revenue Market Share of Adenosine Cobalamin by Type (2019-2030)
Figure 55. Global Adenosine Cobalamin Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Adenosine Cobalamin by Application (2019-2030)
Figure 57. Global Revenue Market Share of Adenosine Cobalamin by Application (2019-2030)
Figure 58. Global Adenosine Cobalamin Price (US$/Unit) by Application (2019-2030)
Figure 59. Adenosine Cobalamin Value Chain
Figure 60. Adenosine Cobalamin Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
